1. Home
  2. ARGX vs RYAAY Comparison

ARGX vs RYAAY Comparison

Compare ARGX & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • RYAAY
  • Stock Information
  • Founded
  • ARGX 2008
  • RYAAY 1985
  • Country
  • ARGX Netherlands
  • RYAAY Ireland
  • Employees
  • ARGX N/A
  • RYAAY N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • RYAAY Air Freight/Delivery Services
  • Sector
  • ARGX Health Care
  • RYAAY Consumer Discretionary
  • Exchange
  • ARGX Nasdaq
  • RYAAY Nasdaq
  • Market Cap
  • ARGX 26.5B
  • RYAAY 22.0B
  • IPO Year
  • ARGX 2017
  • RYAAY 1997
  • Fundamental
  • Price
  • ARGX $542.00
  • RYAAY $112.39
  • Analyst Decision
  • ARGX Strong Buy
  • RYAAY Buy
  • Analyst Count
  • ARGX 20
  • RYAAY 3
  • Target Price
  • ARGX $544.06
  • RYAAY $154.67
  • AVG Volume (30 Days)
  • ARGX 290.6K
  • RYAAY 614.8K
  • Earning Date
  • ARGX 10-29-2024
  • RYAAY 07-22-2024
  • Dividend Yield
  • ARGX N/A
  • RYAAY 2.57%
  • EPS Growth
  • ARGX N/A
  • RYAAY N/A
  • EPS
  • ARGX N/A
  • RYAAY 1.51
  • Revenue
  • ARGX $1,659,620,000.00
  • RYAAY $14,379,727,846.00
  • Revenue This Year
  • ARGX $60.97
  • RYAAY $4.14
  • Revenue Next Year
  • ARGX $41.19
  • RYAAY $10.44
  • P/E Ratio
  • ARGX N/A
  • RYAAY $11.06
  • Revenue Growth
  • ARGX 98.69
  • RYAAY 13.51
  • 52 Week Low
  • ARGX $327.73
  • RYAAY $87.18
  • 52 Week High
  • ARGX $552.83
  • RYAAY $150.73
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 66.68
  • RYAAY 62.13
  • Support Level
  • ARGX $512.04
  • RYAAY $107.58
  • Resistance Level
  • ARGX $552.83
  • RYAAY $113.20
  • Average True Range (ATR)
  • ARGX 8.80
  • RYAAY 2.05
  • MACD
  • ARGX -0.24
  • RYAAY 1.23
  • Stochastic Oscillator
  • ARGX 73.99
  • RYAAY 92.80

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About RYAAY Ryanair Holdings plc

Ryanair Holdings PLC is the airline group by passenger numbers in Europe. The company has two segments: Ryanair DAC and Other Airlines. It derives maximum revenue from Ryanair DAC.

Share on Social Networks: